Original Investigation

Patterns of Health Care Spending in Prostate Cancer

JAMA Network Open 10.1001/jamanetworkopen.2026.33031

September 10, 2026 at 11:00 AM EDT

Read the full article

In this economic evaluation of SEER-Medicare data, spending for prostate cancer–related health care increased substantially from 2012 to 2021, with a marked shift toward systemic therapy. These findings suggest that prolonged systemic treatment has become a dominant component of prostate cancer spending and should be central to future discussions of health care sustainability.

Corresponding Author: Jiaye Shen, PhD, Department of Radiation Oncology, University of Kansas Medical Center, 4001 Rainbow Blvd, Kansas City, KS 66160 (jshen@kumc.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.33031?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091026

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks